CardioDx is a cardiovascular genomic diagnostics company focused on serving cardiologists by offering clinically validated, actionable genomic diagnostics. Our mission is to partner with clinicians in answering complex clinical questions for their patients. We provide timely and reliable information to help clinicians make individualized treatment decisions and improve patient care.
At CardioDx, we are working simultaneously on multiple programs to develop genomic diagnostics for three forms of cardiovascular disease:
- Coronary artery disease
- Cardiac arrhythmias
- Heart failure
Our team is comprised of clinicians, scientists and business executives who have an extensive track record in developing and commercializing medical technology products. CardioDx is a privately held company founded in 2004 and funded by Kleiner, Perkins, Caufield & Byers, Texas Pacific Group Ventures, Mohr Davidow Ventures, and Intel Capital.
| Contact Details: |
| 2500 Faber Place |
| Palo Alto |
| California |
| 94303 |
| United States of America |
| Tel: | 650.475.2788 |
| Fax: | 650.475.2799 |
| Email: | info@cardiodx.com |
| WWW: | www.cardiodx.com/
|
|
Loading...
|
Recent Publications by CardioDx: |  |
Key clinical considerations for demonstrating the utility of preclinical models to predict clinical drug-induced torsades de pointes.
While the QT/QTc interval is currently the best available clinical... | 17th December, 2008
| Cardiovascular Research, CardioDx Inc, Palo Alto, CA 94303, USA.
| Br J Pharmacol. 2008 Aug;154(7):1544-9. Epub 2008 Jun 9.
DOI Direct Link |
Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
OBJECTIVES: This study investigated the role of adrenergic receptor... | 17th September, 2008
| CardioDx, Inc., Palo
| J Am Coll Cardiol. 2008 Aug 19;52(8):644-51. Epub 2008 Jun 23.
DOI Direct Link |
Role of statistics in toxicogenomics.
In this chapter, we provide a structured approach to the statistical... | 6th August, 2008
| Department of BioStatistics, CardioDx, Palo Alto, California, USA.
| Methods Mol Biol. 2008;460:69-87.
DOI Direct Link |
Press Releases on CardioDx:
|
 |
| New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona |
17th November, 2009 |
Heart & Vascular Center of Arizona |
PHOENIX, Nov. 17 /PRNewswire/ -- The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of
|
| CardioDx Announces Appointment of Dr. Louis G. Lange as Chairman of the Board of Directors |
8th October, 2009 |
CardioDx |
PALO ALTO, Calif., Oct. 8 /PRNewswire/ -- CardioDx, a cardiovascular genomic diagnostics company, announced today the appointment of Louis G. Lange, M.D., Ph.D., as Chairman of the company's
|
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 1051 times since April 2007, the link to the organisation's website has been followed 137 times
Recent Search Terms used to find this page: cardiodx | Cardiovascular Research CardioDx Inc Palo Alto CA 94303 | CardioDx | CardioDx | cardiodx | cardiodx email | .
Search for more companies in Palo Alto
Search for more companies in California
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
CardioDx
